Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon

被引:49
作者
Hiraga, Nobuhiko
Imamura, Michio
Tsuge, Masataka
Noguchi, Chiemi
Takahashi, Shoichi
Iwao, Eiji
Fujimoto, Yoshifumi
Abe, Hiromi
Maekawa, Toshiro
Ochi, Hidenori
Tateno, Chise
Yoshizato, Katsutoshi
Sakai, Akihito
Sakai, Yoshio
Honda, Masao
Kaneko, Shuichi
Wakita, Takaji
Chayama, Kazuaki
机构
[1] Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan
[3] Mitsubishi Pharma Corp, Pharmaceut Res Unit, Yokohama, Kanagawa, Japan
[4] RIKEN, Inst Phys & Chem Res, Lab Liver Dis, SNP Res Ctr, Yokohama, Kanagawa, Japan
[5] Prefectural Inst Ind Sci & Technol, Yoshizato Project, CLUSTER, Higashihiroshima, Japan
[6] Hiroshima Univ, Century COE 21, Program Adv Radiat Casualty Med, Dept Biol Sci,Grad Sch Sci, Higashihiroshima 724, Japan
[7] Hiroshima Univ, Dept Biol Lab, Grad Sch Sci, Higashihiroshima 724, Japan
[8] Kanazawa Univ, Dept Gastroenterol, Grad Sch Med, Kanazawa, Ishikawa 920, Japan
关键词
human hepatocyte chimeric mouse; human serum albumin; HCV RNA; interferon;
D O I
10.1016/j.febslet.2007.04.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We developed a reverse genetics system of hepatitis C virus (HCV) genotypes la and 2a using infectious clones and human hepatocyte chimeric mice. We inoculated cell culture-produced genotype 2a (JFH-1) HCV intravenously. We also injected genotype 1a CV-H77C clone RNA intrahepatically. Mice inoculated with HCV by both procedures developed measurable and transmissible viremia. Interferon (IFN) alpha treatment resulted in greater reduction of genotype 2a HCV levels than genotype la, as seen in clinical practice. Genetically engineered HCV infection system should be useful for analysis of the mechanisms of resistance of HCV to IFN and other drugs. (C) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1983 / 1987
页数:5
相关论文
共 21 条
[1]   An infectious molecular clone of a Japanese genotype 1b hepatitis C virus [J].
Beard, MR ;
Abell, G ;
Honda, M ;
Carroll, A ;
Gartland, M ;
Clarke, B ;
Suzuki, K ;
Lanford, R ;
Sangar, DV ;
Lemon, SM .
HEPATOLOGY, 1999, 30 (01) :316-324
[2]   Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy [J].
Chayama, K ;
Suzuki, F ;
Tsubota, A ;
Kobayashi, M ;
Arase, Y ;
Saitoh, S ;
Suzuki, Y ;
Murashima, N ;
Ikeda, K ;
Takahashi, N ;
Kinoshita, M ;
Kumada, H .
HEPATOLOGY, 2000, 32 (05) :1138-1144
[3]   Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection [J].
Enomoto, N ;
Sakuma, I ;
Asahina, Y ;
Kurosaki, M ;
Murakami, T ;
Yamamoto, C ;
Ogura, Y ;
Izumi, N ;
Marumo, F ;
Sato, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02) :77-81
[4]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[5]   INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS [J].
KIYOSAWA, K ;
SODEYAMA, T ;
TANAKA, E ;
GIBO, Y ;
YOSHIZAWA, K ;
NAKANO, Y ;
FURUTA, S ;
AKAHANE, Y ;
NISHIOKA, K ;
PURCELL, RH ;
ALTER, HJ .
HEPATOLOGY, 1990, 12 (04) :671-675
[6]   Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application [J].
Kneteman, Norman M. ;
Weiner, Amy J. ;
O'Connell, John ;
Collett, Marc ;
Gao, Tiejun ;
Aukerman, Lea ;
Kovelsky, Rosemary ;
Ni, Zhi-Jie ;
Hashash, Ahmad ;
Kline, Janine ;
Hsi, Belinda ;
Schiller, Daniel ;
Douglas, Donna ;
Tyrrell, D. Lorne J. ;
Mercer, David F. .
HEPATOLOGY, 2006, 43 (06) :1346-1353
[7]   Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA [J].
Kolykhalov, AA ;
Agapov, EV ;
Blight, KJ ;
Mihalik, K ;
Feinstone, SM ;
Rice, CM .
SCIENCE, 1997, 277 (5325) :570-574
[8]  
Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35
[9]   Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro [J].
Lindenbach, BD ;
Meuleman, P ;
Ploss, A ;
Vanwolleghem, T ;
Syder, AJ ;
McKeating, JA ;
Lanford, RE ;
Feinstone, SM ;
Major, ME ;
Leroux-Roels, G ;
Rice, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) :3805-3809
[10]   Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].
McHutchison, JG ;
Gordon, SC ;
Schiff, ER ;
Shiffman, ML ;
Lee, WM ;
Rustgi, VK ;
Goodman, ZD ;
Ling, MH ;
Cort, S ;
Albrecht, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492